284 related articles for article (PubMed ID: 8032337)
1. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
Balzarini J
Pharm World Sci; 1994 Apr; 16(2):113-26. PubMed ID: 8032337
[TBL] [Abstract][Full Text] [Related]
2. [Anti-retroviral activity and molecular-biochemical action mechanism of 2',3'-dideoxynucleoside analogs and 9-(2-phosphonylmethoxyethyl) purine derivatives].
Balzarini J
Verh K Acad Geneeskd Belg; 1991; 53(1):61-98. PubMed ID: 1647085
[TBL] [Abstract][Full Text] [Related]
3. Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
Thumann-Schweitzer C; Gosselin G; Périgaud C; Benzaria S; Girardet JL; Lefebvre I; Imbach JL; Kirn A; Aubertin AM
Res Virol; 1996; 147(2-3):155-63. PubMed ID: 8901435
[TBL] [Abstract][Full Text] [Related]
4. Lamivudine (3TC) phosphorylation and drug interactions in vitro.
Kewn S; Veal GJ; Hoggard PG; Barry MG; Back DJ
Biochem Pharmacol; 1997 Sep; 54(5):589-95. PubMed ID: 9337075
[TBL] [Abstract][Full Text] [Related]
5. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells.
Cui L; Locatelli L; Xie MY; Sommadossi JP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1228-34. PubMed ID: 9067308
[TBL] [Abstract][Full Text] [Related]
6. Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.
Mathez D; Schinazi RF; Liotta DC; Leibowitch J
Antimicrob Agents Chemother; 1993 Oct; 37(10):2206-11. PubMed ID: 7504908
[TBL] [Abstract][Full Text] [Related]
7. Differential susceptibility of retroviruses to nucleoside analogues.
Rosenblum LL; Patton G; Grigg AR; Frater AJ; Cain D; Erlwein O; Hill CL; Clarke JR; McClure MO
Antivir Chem Chemother; 2001 Mar; 12(2):91-7. PubMed ID: 11527046
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy of human immunodeficiency virus-related disease.
Mitsuya H; Yarchoan R; Kageyama S; Broder S
FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
[TBL] [Abstract][Full Text] [Related]
11. Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria.
Morris GW; Laclair DD; McKee EE
Antivir Ther; 2010; 15(4):587-97. PubMed ID: 20587852
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
[TBL] [Abstract][Full Text] [Related]
13. Sustainable Protocol for the Synthesis of 2',3'-Dideoxynucleoside and 2',3'-Didehydro-2',3'-dideoxynucleoside Derivatives.
Martín-Nieves V; Sanghvi YS; Fernández S; Ferrero M
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807233
[TBL] [Abstract][Full Text] [Related]
14. Comparison of metabolism and in vitro antiviral activity of stavudine versus other 2',3'-dideoxynucleoside analogues.
Sommadossi JP
J Infect Dis; 1995 Mar; 171 Suppl 2():S88-92. PubMed ID: 7861023
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
[TBL] [Abstract][Full Text] [Related]
16. Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues.
Balzarini J; Baba M; Pauwels R; Herdewijn P; De Clerq E
Biochem Pharmacol; 1988 Jul; 37(14):2847-56. PubMed ID: 2840080
[TBL] [Abstract][Full Text] [Related]
17. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
18. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
Gao Q; Gu Z; Hiscott J; Dionne G; Wainberg MA
Antimicrob Agents Chemother; 1993 Jan; 37(1):130-3. PubMed ID: 8381634
[TBL] [Abstract][Full Text] [Related]
19. The antiretroviral and cytostatic activity, and metabolism of 3'-azido-2',3'-dideoxythymidine, 3'-fluoro-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly cell type-dependent.
Balzarini J; Matthes E; Meeus P; Johns DG; De Clercq E
Adv Exp Med Biol; 1989; 253B():407-13. PubMed ID: 2558542
[No Abstract] [Full Text] [Related]
20. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
